← Patent-cliff monitor Loss of exclusivity February 2034 latest FDA-listed patent expiry
Company Novartis → View the full company profile on CliffBio Drug detail Brand name MEKINIST Active ingredient TRAMETINIB DIMETHYL SULFOXIDE Strength EQ 2MG Dosage form TABLET Route ORAL Modality Small molecule FDA approval May 2013 Marketing status RX
Listed patents Patent Expires Type 10869869*PED February 2034 — 10869869 August 2033 use U-3184 9271941*PED July 2032 — 9155706*PED July 2032 — 8580304*PED July 2032 — 9399021*PED July 2032 — 8580304 January 2032 product 9271941 January 2032 product 9399021 January 2032 product 9155706 January 2032 product 8703781*PED April 2031 — 8952018*PED April 2031 — 8703781 October 2030 substance, product 8952018 October 2030 use U-2020 7378423*PED November 2027 — 7378423 May 2027 substance, product
Regulatory exclusivity Code Expires PED September 2030 ODE-428 March 2030 PED September 2026 I-908 March 2026
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.